1. Hsa-miR-133a-3p, miR-1-3p, GOLPH3 and JUP combination results in a good biomarker to distinguish between prostate cancer and non-prostate cancer patients
   Rocío Belén Duca et al, 2022, Frontiers in Oncology CrossRef
2. Expression of GOLPH3 protein in colon cancer tissues and its association with the prognosis of patients
   Bo Zhou et al, 2016, Oncology Letters CrossRef
3. Identification of genes that predict the biochemical recurrence of prostate cancer
   Jianfeng Chu et al, 2018, Oncology Letters CrossRef
4. Prediction of prostate cancer biochemical recurrence by using discretization supports the critical contribution of the extra-cellular matrix genes
   Laura Marin et al, 2023, Scientific Reports CrossRef
5. Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer
   Konrad Sopyllo et al, 2021, Cancers CrossRef
6. Prostate Cancer Biomarkers
   Charalampos Mamoulakis et al, 2019, Biomarkers in Toxicology CrossRef
7. Comparative analysis of GOLPH3 expression in lymph node-positive prostate cancer: immunohistochemistry staining patterns and clinical significance
   Paweł Kiełb et al, 2023, Frontiers in Oncology CrossRef
8. FAP-a and GOLPH3 Are Hallmarks of DCIS Progression to Invasive Breast Cancer
   Li-Na Yu et al, 2019, Frontiers in Oncology CrossRef
9. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma
   Neslihan Komut et al, 2022, Annals of Diagnostic Pathology CrossRef